Hepatic triacylglycerol synthesis and secretion: DGAT2 as the link between glycaemia and triglyceridaemia

Biochemical Journal

Volumn 451, Issue 1, 2013, Pages 1-12

  Zammit, Victor A ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

De novo fatty acid synthesis; Diacylglycerol acyltransferase; Heart; Hypertriglyceridaemia; Intestine; Lipogenesis; Liver; Muscle

Indexed keywords

ACYL COENZYME A OXIDASE; ACYLCARNITINE; ACYLGLYCEROL; CARBOHYDRATE; CARNITINE; CERAMIDE; DIACYLGLYCEROL ACYLTRANSFERASE 1; DIACYLGLYCEROL ACYLTRANSFERASE 2; FATTY ACID; GLUCOSE; GLYCEROL 3 PHOSPHATE ACYLTRANSFERASE; INSULIN; MALONYL COENZYME A; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; VERY LOW DENSITY LIPOPROTEIN;

ADIPOCYTE; ADIPOSE TISSUE; CORRELATIONAL STUDY; ENDOPLASMIC RETICULUM; ENZYME ACTIVE SITE; ENZYME LOCALIZATION; FATTY ACID SYNTHESIS; FATTY LIVER; GLUCOSE BLOOD LEVEL; HEART MUSCLE; HOMEOSTASIS; HUMAN; HYDROLYSIS; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INTESTINE CELL; LIPOGENESIS; LIVER; MUSCLE CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SECRETION; REVIEW; SKELETAL MUSCLE; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; CARBOHYDRATE METABOLISM; DIACYLGLYCEROL O-ACYLTRANSFERASE; FATTY ACIDS; FATTY LIVER; HUMANS; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIVER; TRIGLYCERIDES;

EID: 84875164496     PISSN: 02646021     EISSN: 14708728     Source Type: Journal    
DOI: 10.1042/BJ20121689     Document Type: Review

References (125)

1. White, D. L., Kanwal, F. and El-Serag, H. B. (2012) Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin. Gastroenterol. Hepatol. 10, 1342-1359
2. Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovacs, A., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D. and Kelly, D. P. (2002) The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus. J. Clin. Invest. 109, 121-130
3. Schaffer, J. E. (2003) Lipotoxicity: when tissues overeat. Curr. Opin. Lipidol. 14, 281-287
4. Unger, R. H. (2002) Lipotoxic diseases. Annu. Rev. Med. 53, 319-336
5. Son, N. H., Yu, S., Tuinei, J., Arai, K., Hamai, H., Homma, S., Shulman, G. I., Abel, E. D. and Goldberg, I. J. (2010) PPARγ -induced cardiolipotoxicity in mice is ameliorated by PPARα deficiency despite increases in fatty acid oxidation. J. Clin. Invest. 120, 3443-3454
6. Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B. and Storlien, L. H. (1997) Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46, 983-988
7. Kelley, D. E., Goodpaster, B. H. and Storlien, L. (2002) Muscle triglyceride and insulin resistance. Annu. Rev. Nutr. 22, 325-346
8. Schenk, S. and Horowitz, J. F. (2007) Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance. J. Clin. Invest. 117, 1690-1698
9. van Loon, L. J., Manders, R. J., Koopman, R., Kaastra, B., Stegen, J. H., Gijsen, A. P., Saris, W. H. and Keizer, H. A. (2005) Inhibition of adipose tissue lipolysis increases intramuscular lipid use in type 2 diabetic patients. Diabetologia 48, 2097-2107
10. Zammit, V. A. (1999) The malonyl-CoA-long-chain acyl-CoA axis in the maintenance of mammalian cell function. Biochem. J. 343, 505-515
11. Summers, S. A., Garza, L. A., Zhou, H. and Birnbaum, M. J. (1998) Regulation of insulin-stimulated glucose transporter GLUT4 translocation and Akt kinase activity by ceramide. Mol. Cell. Biol. 18, 5457-5464
12. Liu, L., Zhang, Y., Chen, N., Shi, X., Tsang, B. and Yu, Y. H. (2007) Upregulation ofmyocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. J. Clin. Invest. 117, 1679-1689
13. Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J. et al. (2002) Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J. Biol. Chem. 277, 50230-50236
14. Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F. and Shulman, G. I. (1999) Free fatty acid-induced insulin resistance is associated with activation of protein kinase Cθ and alterations in the insulin signaling cascade. Diabetes 48, 1270-1274
15. Samuel, V. T. and Shulman, G. I. (2012) Mechanisms for insulin resistance: common threads and missing links. Cell 148, 852-871
16. Chavez, J. A. and Summers, S. A. (2012) A ceramide-centric view of insulin resistance. Cell Metab. 15, 585-594
17. Lark, D. S., Fisher-Wellman, K. H. and Neufer, P. D. (2012) High-fat load: mechanism(s) of insulin resistance in skeletal muscle. Int. J. Obes. Suppl. 2, S31-S36
18. Adiels, M., Boren, J., Caslake, M. J., Stewart, P., Soro, A., Westerbacka, J., Wennberg, B., Olofsson, S. O., Packard, C. and Taskinen, M. R. (2005) Overproduction of VLDL1 driven by hyperglycemia is a dominant feature of diabetic dyslipidemia. Arterioscler., Thromb., Vasc. Biol. 25, 1697-1703
19. Taskinen, M. R. (2001) Pathogenesis of dyslipidemia in type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 109 Suppl. 2, S180-S188
20. Malmstrom, R., Packard, C. J., Caslake, M., Bedford, D., Stewart, P., Yki-Jarvinen, H., Shepherd, J. and Taskinen, M. R. (1997) Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia 40, 454-462
21. Abbasi, F., McLaughlin, T., Lamendola, C. and Reaven, G. M. (2000) Insulin regulation of plasma free fatty acid concentrations is abnormal in healthy subjects with muscle insulin resistance. Metabolism 49, 151-154
22. Flowers, M. T. and Ntambi, J. M. (2009) Stearoyl-CoA desaturase and its relation to high-carbohydrate diets and obesity. Biochim. Biophys. Acta 1791, 85-91
23. McLaughlin, T., Abbasi, F., Lamendola, C., Yeni-Komshian, H. and Reaven, G. (2000) Carbohydrate-induced hypertriglyceridemia: an insight into the link between plasma insulin and triglyceride concentrations. J. Clin. Endocrinol. Metab. 85, 3085-3088
24. Olofsson, S. O., Asp, L. and Boren, J. (1999) The assembly and secretion of apolipoprotein B-containing lipoproteins. Curr. Opin. Lipidol. 10, 341-346
25. Cartwright, I. J. and Higgins, J. A. (2001) Direct evidence for a two step assembly of apo-B48 containing lipoproteins in the lumen of the smooth endoplasmic reticulum of rabbit enterocytes. J. Biol. Chem. 276, 48048-48057
26. Liu, P., Ying, Y., Zhao, Y., Mundy, D. I., Zhu, M. and Anderson, R. G. (2004) Chinese hamster ovary K2 cell lipid droplets appear to be metabolic organelles involved in membrane traffic. J. Biol. Chem. 279, 3787-3792
27. Brasaemle, D. L. and Wolins, N. E. (2012) Packaging of fat: an evolving model of lipid droplet assembly and expansion. J. Biol. Chem. 287, 2273-2279
28. Wolins, N. E., Brasaemle, D. L. and Bickel, P. E. (2006) A proposed model of fat packaging by exchangeable lipid droplet proteins. FEBS Lett. 580, 5484-5491
29. Alexander, C. A., Hamilton, R. L. and Havel, R. J. (1976) Subcellular localization of B apoprotein of plasma lipoproteins in rat liver. J. Cell Biol. 69, 241-263
30. Wang, H., Wei, E., Quiroga, A. D., Sun, X., Touret, N. and Lehner, R. (2010) Altered lipid droplet dynamics in hepatocytes lacking triacylglycerol hydrolase expression. Mol. Biol. Cell 21, 1991-2000
31. Kulinski, A., Rustaeus, S. and Vance, J. E. (2002) Microsomal triacylglycerol transfer protein is required for lumenal accretion of triacylglycerol not associated with ApoB, as well as for ApoB lipidation. J. Biol. Chem. 277, 31516-31525
32. Gotto, Jr, A. M. (1998) Triglyceride as a risk factor for coronary artery disease. Am. J. Cardiol. 82, 22Q-25Q
33. Wiggins, D. and Gibbons, G. F. (1992) The lipolysis/esterification cycle of hepatic triacylglycerol. Its role in the secretion of very-low-density- lipoprotein and its response to hormones and sulphonylureas. Biochem. J. 284, 457-462
34. Lankester, D., Brown, A. and Zammit, V. (1998) Use of cytosolic triacylglycerol hydrolysis products and of exogenous fatty cid for the synthesis of triacylglycerol secreted by cultured hepatocytes. J. Lipid Res. 32, 1635-1645
35. Yang, L. Y., Kuksis, A., Myher, J. J. and Steiner, G. (1995) Origin of triacylglycerol moiety of plasma very low density lipoproteins in the rat: structural studies. J. Lipid Res. 36, 125-136
36. Yang, L. Y., Kuksis, A., Myher, J. J. and Steiner, G. (1996) Contribution of de novo fatty acid synthesis to very low density lipoprotein triacylglycerols: evidence from mass isotopomer distribution analysis of fatty acids synthesized from [2H6]ethanol. J. Lipid Res. 37, 262-274
37. Owen, M., Corstorphine, C. G. and Zammit, V. A. (1997) Overt and latent activities of diacylglycerol acyltransferase in rat liver microsomes: possible roles in very-low-density lipoprotein triacylglycerol secretion. Biochem. J. 323, 17-21
38. Owen, M. and Zammit, V. A. (1997) Evidence for overt and latent forms of DGAT in rat liver microsomes. Implications for the pathways of triacylglycerol incorporation into VLDL. Biochem. Soc. Trans. 25, 21S
39. Allan, D. and Thomas, P. (1978) Rapid transbilayer diffusion of 1,2-diacylglycerol and its relevance to control of membrane curvature. Nature 276, 289-290
40. Abo-Hashema, K. A., Cake, M. H., Power, G. W. and Clarke, D. (1999) Evidence for triacylglycerol synthesis in the lumen of microsomes via a lipolysis-esterification pathway involving carnitine acyltransferases. J. Biol. Chem. 274, 35577-35582
41. Broadway, N., Pease, R. and Saggerson, E. (1999) Carnitine acyltransferases and associated transport processes in the endoplasmic reticulum: missing links in the VLDL story? In In Current Views of Fatty acid Oxidation and Ketogenesis: From Organelles to Point Mutations (Quant, P. and Eaton, S., eds), pp. 59-68, Luwer Academic/Plenum Publishers, New York
42. Murthy, M. S. R. and Pande, S. V. (1994) Malonyl-CoA-sensitive and -insensitive carnitine palmitoyltransferase activities of microsomes are due to different proteins. J. Biol. Chem. 269, 18283-18286
43. Zammit, V. A., Buckett, L. K., Turnbull, A. V., Wure, H. and Proven, A. (2008) Diacylglycerol acyltransferases: potential roles as pharmacological targets. Pharmacol. Ther. 118, 295-302
44. Cases, S., Smith, S. J., Zheng, Y. W., Myers, H. M., Lear, S. R., Sande, E., Novak, S., Collins, C., Welch, C. B., Lusis, A. J. et al. (1998) Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis. Proc. Natl. Acad. Sci. U.S.A. 95, 13018-13023
45. Cases, S., Stone, S., Zhou, P., Yen, E., Tow, B., Lardizabal, K. D., Voelker, T. and Farese, Jr, R. V. (2001) Cloning of DGAT2, a second mammalian diacylglycerol acyltransferase, and related family members. J. Biol. Chem. 276, 38870-38876
46. Lardizabal, K. D., Mai, J. T., Wagner, N. W., Wyrick, A., Voelker, T. and Hawkins, D. J. (2001) DGAT2: a new diacylglycerol acyltransferase gene family: purification, cloning and expression in insect cells of two polypeptides from Mortierella ramannniana with diacylglycerol acyltransferase activity. J. Biol. Chem. 276, 38862-38869
47. Cao, J., Cheng, L. and Shi, Y. (2007) Catalytic properties of MGAT3, a putative triacylgycerol synthase. J. Lipid Res. 48, 583-591
48. Sturley, S. L. and Hussain, M. M. (2012) Lipid droplet formation on opposing sides of the endoplasmic reticulum. J. Lipid Res. 53, 1800-1810
49. Stone, S. J., Myers, H. M., Watkins, S. M., Brown, B. E., Feingold, K. R., Elias, P. M. and Farese, Jr, R. V. (2004) Lipopenia and skin barrier abnormalities in DGAT2-deficient mice. J. Biol. Chem. 279, 11767-11776
50. Harris, C. A., Haas, J. T., Streeper, R. S., Stone, S. J., Kumari, M., Yang, K., Han, X., Brownell, N., Gross, R. W., Zechner, R. and Farese, Jr, R. V. (2011) DGAT enzymes are required for triacylglycerol synthesis and lipid droplets in adipocytes. J. Lipid Res. 52, 657-667
51. Cases, S., Zhou, P., Shillingford, J. M., Wiseman, B. S., Fish, J. D., Angle, C. S., Hennighausen, L., Werb, Z. and Farese, Jr, R. V. (2004) Development of the mammary gland requires DGAT1 expression in stromal and epithelial tissues. Development 131, 3047-3055
52. Chen, H. C., Smith, S. J., Ladha, Z., Jensen, D. R., Ferreira, L. D., Pulawa, L. K., McGuire, J. G., Pitas, R. E., Eckel, R. H. and Farese, Jr, R. V. (2002) Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1. J. Clin. Invest. 109, 1049-1055
53. Smith, S. J., Cases, S., Jensen, D. R., Chen, H. C., Sande, E., Tow, B., Sanan, D. A., Raber, J., Eckel, R. H. and Farese, Jr, R. V. (2000) Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat. Nat. Genet. 25, 87-90
54. Orland, M. D., Anwar, K., Cromley, D., Chu, C. H., Chen, L., Billheimer, J. T., Hussain, M. M. and Cheng, D. (2005) Acyl coenzyme A dependent retinol esterification by acyl coenzyme A: diacylglycerol acyltransferase 1. Biochim. Biophys. Acta 1737, 76-82
55. Yen, C. L., Monetti, M., Burri, B. J. and Farese, Jr, R. V. (2005) The triacylglycerol synthesis enzyme DGAT1 also catalyzes the synthesis of diacylglycerols, waxes, and retinyl esters. J. Lipid Res. 46, 1502-1511
56. Shockey, J. M., Gidda, S. K., Chapital, D. C., Kuan, J. C., Dhanoa, P. K., Bland, J. M., Rothstein, S. J., Mullen, R. T. and Dyer, J. M. (2006) Tung tree DGAT1 and DGAT2 have nonredundant functions in triacylglycerol biosynthesis and are localized to different subdomains of the endoplasmic reticulum. Plant Cell 18, 2294-2313
57. Gidda, S. K., Shockey, J. M., Falcone, M., Kim, P. K., Rothstein, S. J., Andrews, D. W., Dyer, J. M. and Mullen, R. T. (2011) Hydrophobic-domain- dependent protein-protein interactions mediate the localization of GPAT enzymes to ER subdomains. Traffic 12, 452-472
58. Man, W. C., Miyazaki, M., Chu, K. and Ntambi, J. (2006) Colocalization of SCD1 and DGAT2: implying preference for endogenous monounsaturated fatty acids in triglyceride synthesis. J. Lipid Res. 47, 1928-1939
59. Xu, N., Zhang, S. O., Cole, R. A., McKinney, S. A., Guo, F., Haas, J. T., Bobba, S., Farese, Jr, R. V. and Mak, H. Y. (2012) The FATP1-DGAT2 complex facilitates lipid droplet expansion at the ER-lipid droplet interface. J. Cell Biol. 198, 895-911
60. Stone, S. J., Levin, M. C. and Farese, Jr, R. V. (2006) Membrane topology and identification of key functional amino acid residues of murine acyl-CoA:diacylglycerol acyltransferase-2. J. Biol. Chem. 281, 40273-40282
61. Stone, S. J., Levin, M. C., Zhou, P., Han, J., Walther, T. C. and Farese, Jr, R. V. (2009) The endoplasmic reticulum enzyme DGAT2 is found in mitochondria-associated membranes and has a mitochondrial targeting signal that promotes its association with mitochondria. J. Biol. Chem. 284, 5352-5361
62. Wurie, H. R., Buckett, L. and Zammit, V. A. (2011) Evidence that diacylglycerol acyltransferase 1 (DGAT1) has dual membrane topology in the endoplasmic reticulum of HepG2 cells. J. Biol. Chem. 286, 36238-36247
63. Wurie, H. R., Buckett, L. and Zammit, V. A. (2012) Diacylglycerol acyltransferase 2 acts upstream of diacylglycerol acyltransferase 1 and utilizes nascent diglycerides and de novo synthesized fatty acids in HepG2 cells. FEBS J. 279, 3033-3047
64. McFie, P. J., Stone, S. L., Banman, S. L. and Stone, S. J. (2010) Topological orientation of acyl-CoA:diacylglycerol acyltransferase-1 (DGAT1) and identification of a putative active site histidine and the role of the N terminus in dimer/tetramer formation. J. Biol. Chem. 285, 37377-37387
65. Yamazaki, T., Sasaki, E., Kakinuma, C., Yano, T., Miura, S. and Ezaki, O. (2005) Increased very low density lipoprotein secretion and gonadal fat mass in mice overexpressing liver DGAT1. J. Biol. Chem. 280, 21506-21514
66. Cheng, D., Meegalla, R. L., He, B., Cromley, D. A., Billheimer, J. T. and Young, P. R. (2001) Human acyl-CoA:diacylglycerol acyltransferase is a tetrameric protein. Biochem. J. 359, 707-714
67. Chen, Y. J., Pornillos, O., Lieu, S., Ma, C., Chen, A. P. and Chang, G. (2007) X-ray structure of EmrE supports dual topology model. Proc. Natl. Acad. Sci. U.S.A. 104, 18999-19004
68. Lolkema, J. S., Dobrowolski, A. and Slotboom, D. J. (2008) Evolution of antiparallel two-domain membrane proteins: tracing multiple gene duplication events in the DUF606 family. J. Mol. Biol. 378, 596-606
69. Rapp, M., Granseth, E., Seppala, S. and von Heijne, G. (2006) Identification and evolution of dual-topology membrane proteins. Nat. Struct. Mol. Biol. 13, 112-116
70. Sebag, J. A. and Hinkle, P. M. (2009) Regions of melanocortin 2 (MC2) receptor accessory protein necessary for dual topology and MC2 receptor trafficking and signaling. J. Biol. Chem. 284, 610-618
71. Gouffi, K., Gerard, F., Santini, C. L. and Wu, L. F. (2004) Dual topology of the Escherichia coli TatA protein. J. Biol. Chem. 279, 11608-11615
72. Waterman, I. J. and Zammit, V. A. (2002) Differential effects of fenofibrate or simvastatin treatment of rats on hepatic microsomal overt and latent diacylglycerol acyltransferase activities. Diabetes 51, 1708-1713
73. Bogdanov, M. and Dowhan, W. (2012) Lipid-dependent generation of dual topology for a membrane protein. J. Biol. Chem. 287, 37939-37948
74. Dowhan, W. and Bogdanov, M. (2012) Molecular genetic and biochemical approaches for defining lipid-dependent membrane protein folding. Biochim. Biophys. Acta 1818, 1097-1107
75. Quiroga, A. D. and Lehner, R. (2011) Role of endoplasmic reticulum neutral lipid hydrolases. Trends Endocrinol. Metab. 22, 218-225
76. Azain, M. J., Fukuda, N., Chao, F. F., Yamamoto, M. and Ontko, J. A. (1985) Contributions of fatty acid and sterol synthesis to triglyceride and cholesterol secretion by the perfused rat liver in genetic hyperlipemia and obesity. J. Biol. Chem. 260, 174-181
77. Fukuda, N., Azain, M. J. and Ontko, J. A. (1982) Altered hepatic metabolism of free fatty acids underlying hypersecretion of very low density lipoproteins in the genetically obese Zucker rats. J. Biol. Chem. 257, 14066-14072
78. Fukuda, N. and Ontko, J. A. (1984) Interactions between fatty acid synthesis, oxidation, and esterification in the production of triglyceride-rich lipoproteins by the liver. J. Lipid Res. 25, 831-842
79. Miyazaki, M., Kim, Y. C., Gray-Keller, M. P., Attie, A. D. and Ntambi, J. M. (2000) The biosynthesis of hepatic cholesterol esters and triglycerides is impaired in mice with a disruption of the gene for stearoyl-CoA desaturase 1. J. Biol. Chem. 275, 30132-30138
80. Shimomura, I., Bashmakov, Y., Ikemoto, S., Horton, J. D., Brown, M. S. and Goldstein, J. L. (1999) Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc. Natl. Acad. Sci. U.S.A. 96, 13656-13661
81. Brown, M. S. and Goldstein, J. L. (2008) Selective versus total insulin resistance: a pathogenic paradox. Cell Metab. 7, 95-96
82. Chu, K., Miyazaki, M., Man, W. C. and Ntambi, J. M. (2006) Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation. Mol. Cell. Biol. 26, 6786-6798
83. Hellerstein, M. K., Schwarz, J. M. and Neese, R. A. (1996) Regulation of hepatic de novo lipogenesis in humans. Annu. Rev. Nutr. 16, 523-557
84. Hudgins, L. C., Hellerstein, M., Seidman, C., Neese, R., Diakun, J. and Hirsch, J. (1996) Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet. J. Clin. Invest. 97, 2081-2091
85. Francone, O. L., Kalopissis, A. D. and Griffaton, G. (1989) Contribution of cytoplasmic storage triacylglycerol to VLDL-triacylglycerol in isolated rat hepatocytes. Biochim. Biophys. Acta 1002, 28-36
86. Zammit, V. A. (1996) Role of insulin in hepatic fatty acid partitioning: emerging concepts. Biochem. J. 314, 1-14
87. Qi, J., Lang, W., Geisler, J. G., Wang, P., Petrounia, I., Mai, S., Smith, C., Askari, H., Struble, G. T., Williams, R. et al. (2012) The use of stable isotope-labeled glycerol and oleic acid to differentiate the hepatic functions of diacylglycerol acyltransferase-1 and -2. J. Lipid Res. 53, 1106-1116
88. Aarsland, A., Chinkes, D. and Wolfe, R. R. (1996) Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/ hyperinsulinemia in normal man. J. Clin. Invest. 98, 2008-2017
89. Miyazaki, M., Kim, Y. C. and Ntambi, J. M. (2001) A lipogenic diet in mice with a disruption of the stearoyl-CoA desaturase 1 gene reveals a stringent requirement of endogenous monounsaturated fatty acids for triglyceride synthesis. J. Lipid Res. 42, 1018-1024
90. Kuerschner, L., Moessinger, C. and Thiele, C. (2008) Imaging of lipid biosynthesis: how a neutral lipid enters lipid droplets. Traffic 9, 338-352
91. Millar, J. S., Stone, S. J., Tietge, U. J., Tow, B., Billheimer, J. T., Wong, J. S., Hamilton, R. L., Farese, Jr, R. V. and Rader, D. J. (2006) Short-term hepatic overexpression of DGAT1 or DGAT2 in female mice increases hepatic triglyceride synthesis without changing VLDL triglyceride or ApoB production. J. Lipid Res. 47, 2297-2305
92. Villanueva, C. J., Monetti, M., Shih, M., Zhou, P., Watkins, S. M., Bhanot, S. and Farese, Jr, R. V. (2009) Specific role for acyl CoA:diacylglycerol acyltransferase 1 (Dgat1) in hepatic steatosis due to exogenous fatty acids. Hepatology 50, 434-442
93. Ganji, S. H., Tavintharan, S., Zhu, D., Xing, Y., Kamanna, V. S. and Kashyap, M. L. (2004) Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells. J. Lipid Res. 45, 1835-1845
94. Hu, M., Chu, W. C., Yamashita, S., Yeung, D. K., Shi, L., Wang, D., Masuda, D., Yang, Y. and Tomlinson, B. (2012) Liver fat reduction with niacin is influenced by DGAT-2 polymorphisms in hypertriglyceridemic patients. J. Lipid Res. 53, 802-809
95. Tobey, T. A., Greenfield, M., Kraemer, F. and Reaven, G. M. (1981) Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics, and plasma triglyceride levels in normotriglyceridemic man. Metabolism 30, 165-171
96. Chirieac, D. V., Chirieac, L. R., Corsetti, J. P., Cianci, J., Sparks, C. E. and Sparks, J. D. (2000) Glucose-stimulated insulin secretion suppresses hepatic triglyceride-rich lipoprotein and apoB production. Am. J. Physiol. Endocrinol. Metab. 279, E1003-E1011
97. Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y., Brown, M. S. and Goldstein, J. L. (2000) Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob /ob mice. Mol. Cell 6, 77-86
98. Biddinger, S. B., Hernandez-Ono, A., Rask-Madsen, C., Haas, J. T., Aleman, J. O., Suzuki, R., Scapa, E. F., Agarwal, C., Carey, M. C., Stephanopoulos, G. et al. (2008) Hepatic insulin resistance is sufficient to produce dyslipidemia and susceptibility to atherosclerosis. Cell Metab. 7, 125-134
99. Rennie, S. M., Park, B. S. and Zammit, V. A. (2000) A switch in the direction of the effect of insulin on the partitioning of hepatic fatty acids for the formation of secreted triacylglycerol occurs in vivo, as predicted from studies with perfused livers. Eur. J. Biochem. 267, 935-941
100. Zammit, V. A. (2002) Insulin stimulation of hepatic triacylglycerol secretion in the insulin-replete state: implications for the etiology of peripheral insulin resistance. Ann. N. Y. Acad. Sci. 967, 52-65
101. Zammit, V. A., Waterman, I. J., Topping, D. and McKay, G. (2001) Insulin stimulation of hepatic triacylglycerol secretion and the etiology of insulin resistance. J. Nutr. 131, 2074-2077
102. Zammit, V. A., Lankester, D. J., Brown, A. M. and Park, B. S. (1999) Insulin stimulates triacylglycerol secretion by perfused livers from fed rats but inhibits it in livers from fasted or insulin-deficient rats implications for the relationship between hyperinsulinaemia and hypertriglyceridaemia. Eur. J. Biochem. 263, 859-864
103. Wiggins, D., Hems, R. and Gibbons, G. F. (1995) Decreased sensitivity to the inhibitory effect of insulin on the secretion of very-low-density lipoprotein in cultured hepatocytes from fructose-fed rats. Metabolism 44, 841-847
104. Moir, A. M. and Zammit, V. A. (1994) Effects of insulin treatment of diabetic rats on hepatic partitioning of fatty acids between oxidation and esterification, phospholipid and acylglycerol synthesis, and on the fractional rate of secretion of triacylglycerol in vivo. Biochem. J. 304, 177-182
105. Zammit, V. A. and Moir, A. M. (1994) Monitoring the partitioning of hepatic fatty acids in vivo: keeping track of control. Trends Biochem. Sci. 19, 313-317
106. Li, S., Brown, M. S. and Goldstein, J. L. (2010) Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis. Proc. Natl. Acad. Sci. U.S.A. 107, 3441-3446
107. Hsieh, J., Hayashi, A. A., Webb, J. and Adeli, K. (2008) Postprandial dyslipidemia in insulin resistance: mechanisms and role of intestinal insulin sensitivity. Atherosclerosis Suppl. 9, 7-13
108. Cheng, D., Nelson, T. C., Chen, J., Walker, S. G., Wardwell-Swanson, J., Meegalla, R., Taub, R., Billheimer, J. T., Ramaker, M. and Feder, J. N. (2003) Identification of acyl coenzyme A:monoacylglycerol acyltransferase 3, an intestinal specific enzyme implicated in dietary fat absorption. J. Biol. Chem. 278, 13611-13614
109. Buhman, K. K., Smith, S. J., Stone, S. J., Repa, J. J., Wong, J. S., Knapp, Jr, F. F., Burri, B. J., Hamilton, R. L., Abumrad, N. A. and Farese, Jr, R. V. (2002) DGAT1 is not essential for intestinal triacylglycerol absorption or chylomicron synthesis. J. Biol. Chem. 277, 25474-25479
110. Ables, G. P., Yang, K. J., Vogel, S., Hernandez-Ono, A., Yu, S., Yuen, J. J., Birtles, S., Buckett, L. K., Turnbull, A. V., Goldberg, I. J. et al. (2012) Intestinal DGAT1 deficiency reduces postprandial triglyceride and retinyl ester excursions by inhibiting chylomicron secretion and delaying gastric emptying. J. Lipid Res. 53, 2364-2379
111. Lee, B., Fast, A. M., Zhu, J., Cheng, J. X. and Buhman, K. K. (2010) Intestine-specific expression of acyl CoA:diacylglycerol acyltransferase 1 reverses resistance to diet-induced hepatic steatosis and obesity in Dgat1 -/- mice. J. Lipid Res. 51, 1770-1780
112. Haidari, M., Leung, N., Mahbub, F., Uffelman, K. D., Kohen-Avramoglu, R., Lewis, G. F. and Adeli, K. (2002) Fasting and postprandial overproduction of intestinally derived lipoproteins in an animal model of insulin resistance. Evidence that chronic fructose feeding in the hamster is accompanied by enhanced intestinal de novo lipogenesis and ApoB48-containing lipoprotein overproduction. J. Biol. Chem. 277, 31646-31655
113. Levin, M. C., Monetti, M., Watt, M. J., Sajan, M. P., Stevens, R. D., Bain, J. R., Newgard, C. B., Farese, Sr, R. V. and Farese, Jr, R. V. (2007) Increased lipid accumulation and insulin resistance in transgenic mice expressing DGAT2 in glycolytic (type II) muscle. Am. J. Physiol. Endocrinol. Metab. 293, E1772-E1781
114. Pan, D. A., Mater, M. K., Thelen, A. P., Peters, J. M., Gonzalez, F. J. and Jump, D. B. (2000) Evidence against the peroxisome proliferator-activated receptor α (PPARα) as the mediator for polyunsaturated fatty acid suppression of hepatic L-pyruvate kinase gene transcription. J. Lipid Res. 41, 742-751
115. Goodpaster, B. H., He, J., Watkins, S. and Kelley, D. E. (2001) Skeletal muscle lipid content and insulin resistance: evidence for a paradox in endurance-trained athletes. J. Clin. Endocrinol. Metab. 86, 5755-5761
116. Russell, A. P. (2004) Lipotoxicity: the obese and endurance-trained paradox. Int. J. Obes. Relat. Metab. Disord. 28 (Suppl. 4), S66-S71
117. Bengtsson, G. and Olivecrona, T. (1980) Lipoprotein lipase. Mechanism of product inhibition. Eur. J. Biochem. 106, 557-562
118. Fielding, B. A. and Frayn, K. N. (1998) Lipoprotein lipase and the disposition of dietary fatty acids. Br. J. Nutr. 80, 495-502
119. Erion, D. M. and Shulman, G. I. (2010) Diacylglycerol-mediated insulin resistance. Nat. Med. 16, 400-402
120. Liu, L., Shi, X., Bharadwaj, K. G., Ikeda, S., Yamashita, H., Yagyu, H., Schaffer, J. E., Yu, Y. H. and Goldberg, I. J. (2009) DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity. J. Biol. Chem. 284, 36312-36323
121. Dube, J. J., Amati, F., Stefanovic-Racic, M., Toledo, F. G., Sauers, S. E. and Goodpaster, B. H. (2008) Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete's paradox revisited. Am. J. Physiol. Endocrinol. Metab. 294, E882-E888
122. Amati, F., Dube, J. J., Alvarez-Carnero, E., Edreira, M. M., Chomentowski, P., Coen, P. M., Switzer, G. E., Bickel, P. E., Stefanovic-Racic, M., Toledo, F. G. and Goodpaster, B. H. (2011) Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes? Diabetes 60, 2588-2597
123. Aas, V., Kase, E. T., Solberg, R., Jensen, J. and Rustan, A. C. (2004) Chronic hyperglycaemia promotes lipogenesis and triacylglycerol accumulation in human skeletal muscle cells. Diabetologia 47, 1452-1461
124. Turcotte, L. P., Swenberger, J. R. and Yee, A. J. (2002) High carbohydrate availability increases LCFA uptake and decreases LCFA oxidation in perfused muscle. Am. J. Physiol. Endocrinol. Metab. 282, E177-E183
125. Payne, V. A., Au, W. S., Gray, S. L., Nora, E. D., Rahman, S. M., Sanders, R., Hadaschik, D., Friedman, J. E., O'Rahilly, S. and Rochford, J. J. (2007) Sequential regulation of diacylglycerol acyltransferase 2 expression by CAAT/enhancer-binding protein β (C/EBPβ) and C/EBPα during adipogenesis. J. Biol. Chem. 282, 21005-21014